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To assess the effect of normobaric hypoxia on metabolism, gut hormones, and body
composition, 11 normal weight, aerobically trained (V˙O −1 −1± · ·2peak: 60.6 9.5ml kg min )
men (73.0 ± 7.7 kg; 23.7 ± 4.0 years, BMI 22.2 ± 2.4 kg·m−2) were confined to
a normobaric (altitude ≃ 940 m) normoxic (NORMOXIA; PIO ≃2 133.2mmHg) or
normobaric hypoxic (HYPOXIA; PIO was reduced from 105.6 to 97.7mmHg over 10
days) environment for 10 days in a randomized cross-over design. The wash-out period
between confinements was 3 weeks. During each 10-day period, subjects avoided
strenuous physical activity and were under continuous nutritional control. Before, and at
the end of each exposure, subjects completed a meal tolerance test (MTT), during which
blood glucose, insulin, GLP-1, ghrelin, peptide-YY, adrenaline, noradrenaline, leptin, and
gastro-intestinal blood flow and appetite sensations were measured. There was no
significant change in body weight in either of the confinements (NORMOXIA: −0.7± 0.2
kg; HYPOXIA: −0.9 ± 0.2 kg), but a significant increase in fat mass in NORMOXIA
(0.23 ± 0.45 kg), but not in HYPOXIA (0.08 ± 0.08 kg). HYPOXIA confinement increased
fasting noradrenaline and decreased energy intake, the latter most likely associated with
increased fasting leptin. The majority of all other measured variables/responses were
similar in NORMOXIA and HYPOXIA. To conclude, normobaric hypoxic confinement
without exercise training results in negative energy balance due to primarily reduced
energy intake.
Keywords: altitude, hypoxia, metabolism, appetite, energy expenditure
INTRODUCTION
A common consequence of exposure to high altitude (>2500m) is an unexplained loss of body
weight (Boyer and Blume, 1984; Guilland and Klepping, 1985; Rose et al., 1988; Westerterp et al.,
1992; Pulfrey and Jones, 1996; Barry and Pollard, 2003), which appears to be dependent on the
nature of the hypoxic stimulus (Kayser, 1994; Mazzeo, 2008). Weight loss at high altitude was
observed even in the absence of symptoms of mountain sickness (Tschöp and Morrison, 2001),
which is known to affect appetite. Most of the field studies conducted to date have not been able
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to control for potentially confounding variables, such as cold,
physical exertion, limited palatable food at altitude, thus the effect
of hypoxia per se on the etiology of “high altitude anorexia”
remains unresolved.
The suggested likely reasons for body-weight loss at altitude
are a decrease in appetite, and the associated decrease in energy
intake (Kalson et al., 2010). Laboratory trials have demonstrated
appetite suppression after a simulated 31-day hypobaric hypoxic
exposure to 8848m (Westerterp-Plantenga et al., 1999), and it
was suggested that the hormone leptin may mediate altitude
anorexia (Tschöp et al., 1998). Leptin serves as an adiposity signal
to inform the brain of the adipose tissue mass in a negative
feedback loop regulating food intake and energy expenditure.
However, observations of the effect of hypoxia on leptin levels
are conflicting. Namely, studies have reported increased (Shukla
et al., 2005; Snyder et al., 2008), decreased (Zaccaria et al., 2004;
Vats et al., 2007), or unchanged (Barnholt et al., 2006) leptin levels
during hypoxic exposure. Moreover, the endocrine factors that
contribute to the observed changes in body weight at altitude
remain unclear. It has been suggested that absorption of nutrients
is slowed, and possibly impaired, at altitude (Milledge, 1972;
Schoots et al., 2006). Recently, the observation of suppression
of energy intake and of the appetite hormone, ghrelin, after
a 7-h normobaric hypoxic exposure, suggested that short-term
hypoxia per se, in the absence of cold and other stressors may
be implicated in high altitude anorexia (Wasse et al., 2012).
However, after prolonged hypoxia (range of duration: 7 days to
7 weeks), ghrelin was unchanged at altitude (Shukla et al., 2005).
Shukla et al. (2005) reported that the peptide YY (PYY), which
reduces appetite or promotes satiety, was not significantly altered
after acute normobaric hypoxia. Thus, the effect of prolonged (a
few days) normobaric hypoxia on this gut hormone, which could
potentially contribute to weight loss, remains unresolved.
Energy expenditure (EE) is influenced by oxygen supply.
However, the observations of the effect of hypoxia on resting
EE (REE) are conflicting. Though the majority of studies report
an increase (Picon-Reategui, 1961; Grover, 1963; Gill and Pugh,
1964; Butterfield et al., 1992), a few have shown no change in
altitude REE (Durnin and Brockway, 1959; Westerterp et al.,
1992, 1994). Of the former, values of EE in climbers have been
reported to be comparable to highly trained endurance athletes
at sea level (Westerterp et al., 1992).
Weight loss resulting from an imbalance between energy
intake and expenditure may be related to other factors, such as
nutrient intake, digestibility and altered fluid balance. Weight
loss at altitude has also been attributed to the initial loss of water,
and subsequent loss of fat and muscle mass due to malnutrition
(Kayser, 1994). Westerterp (2001) concluded that weight loss is
mainly caused by malnutrition due to hypoxia-related satiety,
independent of acute mountain sickness. Moreover, decreased
xylose absorption with more severe desaturation was noted
(Milledge, 1972), confirming the notion that hypoxia followed
by reoxygenation impairs nutrient absorption (Schoots et al.,
2006). However, hypoxia is believed to be a major factor in
the development, and progression of metabolic alterations in
glucose metabolism (Stock et al., 1978; Louis and Punjabi, 2009).
The observed reduction in baseline and postprandial gut blood
flow [superior mesenteric artery (SMA)] during acute altitude
exposure has been attributed to increased intestinal sympathetic
tone, and it has been suggested that this could lead to reduced
energy intake during prolonged exposure (Loshbaugh et al.,
2006).
The above empirical, and also anecdotal evidence of
weight loss following high altitude expeditions, suggests that
hypoxia may also induce weight loss in athletes conducting
hypoxic training (i.e., simulated altitude training) to improve
performance (Richalet and Gore, 2008; Siebenmann et al., 2012).
Such weight loss may be beneficial, if it affected the fat tissue
compartment, but detrimental if it reduced muscle mass, and/or
reflected dehydration. Without knowledge of the nature of
hypoxia-induced reductions in body mass, advocating hypoxic
training in weight-loss programmes may be unwarranted (Netzer
et al., 2008; Wasse et al., 2012). As a prelude to a study
investigating the effect of normobaric hypoxia on the metabolism
in overweight and obese individuals, we initiated the present
study on normal weight and active subjects. Consequently, this
study exposed individuals to a moderate altitude of only 3000
m, mainly due to precautionary measures, and partly since the
majority of the studies to date have been conducted at higher
altitudes. A principal concern in establishing the protocol of
this and future such studies, was that hypoxia may initiate a
significant cardiorespiratory stress, which may be acceptable in
normal weight active subjects, but perhaps of more concern in
an overweight, inactive subject population. Since very few studies
have been conducted with the latter population at altitude, a
conservative approach to hypoxic exposure of such individuals
was warranted. An additional concern was that the obstructive
sleep apnea observed in overweight and obese individuals might
be augmented by hypoxia-induced central sleep apnea, and thus
might pose an additional cardiorespiratory stress. The present
study was therefore not designed to determine the threshold
altitude at which changes in metabolism would be observed, but
to determine the changes in metabolism, if any, at an altitude that
would be considered safe for overweight and obese individuals,
should the responses observed in normal weight subjects warrant
consideration of hypoxia as a potential factor for inducing weight
reduction.
The present study tested the hypothesis that a continuous 10-
day hypoxic confinement in healthy normal weightmales induces
metabolic changes reflected in changes in REE, gastrointestinal
hormones and appetite, which may lead to loss of body weight,
and in turn may provide some insight into the phenomenon of
high-altitude anorexia.
METHODS
Subjects
Eleven healthy aerobically trained males (mean ± SD age and
stature of 23.7 ± 4.0 years and 181 ± 9 cm), all low altitude
(351 ± 103 m; FIO2 = 0.21) residents, participated in two 10-
day confinements. Subject exclusion criteria included a history
of physician-diagnosed medical problems, recent prolonged
exposure to normobaric or hypobaric hypoxia, or recent weight
loss, participation in any dietary manipulations in the past 6
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months, and use of any medications or drugs. All participants
gave their written informed consent to participate in the study.
The study protocol was approved by the National Committee for
Medical Ethics at the Ministry of Health of the Republic Slovenia
and conformed to the Declaration of Helsinki.
Experimental Protocol
The study was conducted at the Olympic Sport Centre Planica
(Ratecˇe, Slovenia) situated at an altitude of 940m. Subjects
participated in two confinements, during which they were
confined to one floor of the facility. The study was designed as
a randomized cross-over study. Participants were assigned to two
groups: one group (n = 6) was initially confined to a normobaric
normoxic environment (NORMOXIA; inspired fraction of O2,
FIO2 = 0.209; PIO2 ≃ 133.2mmHg) for 10 days and the other
(n = 5) to a controlled normobaric hypoxic environment
(HYPOXIA). As shown in Figure 1, subjects were exposed to
a simulated altitude of 2800m (PIO2 = 105.6mmHg) for the
first 2 days (days 1 and 2). Thereafter the fraction of oxygen in
the facility was reduced every 2 days, so that the subjects were
exposed to a simulated altitude of 3000m (PIO2 = 102.9mmHg)
on days 3 and 4, to 3200m (PIO2 = 100.2mmHg) on days 5 and
6, and finally to 3400m (PIO2 = 97.7mmHg) for the remaining
4 days. In both trials, the participants arrived at the facility 5
days prior to the onset of the 10-day confinement. During these
5 days, they were familiarized with the experimental protocol
and equipment, and baselinemeasurements were obtained. Upon
completion of the 10-day confinements, subjects remained at
the facility for an additional 4 days for the post-confinement
tests. The meal tolerance test (MTT) and the assessment of
resting oxygen uptake (V˙O2rest) were performed before and after
each confinement. In the HYPOXIA confinement, once these
tests were completed, the subjects remained under normoxic
conditions for the next 4 days. After a 3-week wash-out period
the subjects returned to the Olympic Sport Centre Planica, and
the conditions were crossed-over.
During both the NORMOXIA and HYPOXIA trials, subjects
were confined to the living quarters (each group had at their
disposal 3 double sleeping rooms and one living/dining room;
total area of ∼90 m2). In the HYPOXIA trial, the reduction in
FIO2 was achieved with an oxygen dilution system (B-cat, the
Netherlands), based on the Vacuum-Pressure Swing Adsorption
principle. The oxygen levels in each room were monitored and
recorded at 15-min intervals throughout the 10-day period. In
the event that the oxygen fraction in any given room decreased
below the pre-set value, delivery of the hypoxic gas mixture to
that room was stopped. In the event that the oxygen fraction
dropped by more than 0.5% of the pre-set value, the control
system activated a fan, which delivered external ambient air into
that room. As a consequence of the fan being activated, the
oxygen fraction in the roomwould increase rapidly to the desired
level. Once the oxygen fraction attained the pre-set value, the
fan would be de-activated. Each subject was also requested to
either wear, or have in close proximity, a personal clip-on type
of environmental oxygen analyser (Rae PGM-1100, California,
USA) with an audible alarm that was activated in the event that
the oxygen level decreased below the pre-set level.
Prior to the onset of the study, subjects completed
questionnaires regarding their current and past health status,
habitual physical activity levels, dietary habits, and food
preferences. During the 5-day period prior to each confinement,
subjects were requested to record their dietary intake in a
food diary. During the 10-day confinement period, subjects
were restricted from any high-intensity, or aerobic exercise.
Physical activity was restricted to slow walks in the living
area. Nutritional choices and energy intake were documented
in daily nutritional diaries during both trials. The food menu
comprised typical national foods, freely available, and an effort
was made to accommodate individual food preferences. The
subjects received the same food menu during each 10-day
exposure, but without any restriction regarding the quantity
consumed; they ate and drank ad libitum. The daily energy
intake was recorded and analyzed with a dietary assessment
program (OPKP, Jozef Stefan Institute, Ljubljana, Slovenia).
Subjects’ well-being was monitored by medical personnel. All
participants had personal pulse oxymeters (Nonin,Medicals 3100
WristOx, Minnesota, USA) monitoring capillary oxyhemoglobin
saturation (SpO2) and heart rate (HR). Symptoms of mountain
sickness and individual mood and appetite were monitored daily
with the Lake Louise Scoring system (LLS) and Visual Analog
Scale (VAS) for Mood and Appetite, respectively. The metabolic
tests were conducted in a normoxic environment, 3 days prior
to the onset of each 10-day confinement (pre-test), and on the
morning of the completion of the confinement period (post-test).
Namely, the confinements commenced at 9:00 a.m. on day 1, and
were terminated at 9:00 on day 11.
Diet
The menus were constructed using the application Open
Platform for Clinical Nutrition (OPKP; www.opkp.si) developed
at the Jozef Stefan Institute (Ljubljana, Slovenia). Five daily meals
(breakfast, morning snack, lunch, afternoon snack, dinner) were
prepared by the kitchen staff of theOlympic Sport Centre Planica,
and the components weighed to ±1 g accuracy. Meals were
served at the same time of day during both normoxic and hypoxic
trials. The analysis of energy, macronutrient, and fluid intake
was conducted for each subject using the OPKP programme.
An example of a 10-day menu has been presented previously
(Debevec et al., 2014).
Anthropometry
Body composition was analyzed before and after each 10-
day confinement with Dual-Emission X-ray absorptiometry
(Discovery, Hologic, Inc., Bedford USA). Measurements were
made of total body fat mass and regional fat mass (abdominal,
right thigh, left thigh) and fat-free mass. Body weight and
height were measured with a weighing scale and a stadiometer,
respectively (Seca 703, Seca, Hamburg, Germany).
Aerobic Capacity
All subjects performed an incremental exercise test to exhaustion
on a cycle-ergometer (Daum electronics, Fürth, Germany) 3
days prior to, and 1 day after, each confinement (Figure 1), to
determine their V˙O2peak. The trial was performed around noon.
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FIGURE 1 | Experimental protocol. Subjects (N = 11) participated in two 10-day confinements. In one they were confined to a normobaric normoxic environment
(NORMOXIA), and in the other to a progressive normobaric hypoxic environment (HYPOXIA). Each confinement was preceded by a 5-day period, during which
baseline measurements were obtained (DEXA, Body composition was measured with Dual Energy X-Ray Absorption; MTT, Meal Toelrance Test; VO2max, maximal
oxygen uptake test). Subjects remained at the facility 4 days following each confinement for post measurements.
The post-trial was carried out ∼3 h after the termination of
the confinement; during this period, subjects, who were always
supervised by an assistant, were requested to stay in the facility,
and not to engage in any strenuous physical activity. Also,
according to the schedule, subjects consumed a standardized
breakfast around 7:30 a.m., and a light snack (i.e., fruit)
approximately an hour before the trial. The V˙O2peak testing
protocol comprised a 5-min resting period, during which subjects
remained still and seated on the cycle-ergometer and V˙O2rest
was determined.
After a 2-min warm-up at 60W, the workload was
incremented each minute by 25W, until exhaustion. Inability
to maintain the cycling cadence above 60 rpm, plateau in V˙O2
and/or a respiratory exchange ratio >1.1, were the criteria used,
to confirm the attainment of the V˙O2peak (calculated as the
highest VO2peak averaged over 60 s during the test). V˙O2 was
measured breath-by-breath with a Quark CPET metabolic cart
(Cosmed, Quark PFT, Rome, Italy).
Metabolic Test
Prior to, and on the final day of each 10-day confinement,
subjects completed a MTT to assess their fasting metabolic status
and the postprandial metabolic responses. For 2 days before
the pre-confinement metabolic experiments, subjects refrained
from exercising and were under dietary control with limited
caffeine (daily maximum caffeine content: 150mg) and alcohol
(daily maximum alcohol content: 8 g or 10ml) consumption. The
dietary intake diaries obtained prior to each MTT revealed that
the macronutrient composition was similar for the NORMOXIA
and HYPOXIA trials. The last meal prior to the MTT was the
evening meal the day before the test. For each subject and MTT,
the composition of the last meal prior to the 12-h fast was the
same.
One hour after subjects completed their morning personal
hygiene and morning body weighing, they relaxed and rested
supine for 3 h during the metabolic test. The metabolic tests were
conducted at the same time of the day for each subject (between
07:00 a.m. and 01:00 p.m.); the environmental conditions were
kept constant: the mean ambient temperature and relative
humidity were 25± 0.8◦C and 37.5± 4.7%, respectively.
For the MTT, subjects consumed a standardized mixed
nutrient liquid test meal (Ensure, Nutrition shake, vanilla flavor;
Abbott) based on their individual body weight (5ml·kg−1,
1.5 kcal·ml−1) determined on the day of the experiment.
Additionally, 13C-labeled glucose (9.2 mg·kg−1) was added to the
test meal as an indicator of gastric emptying, and glucose uptake
and use (expired 13CO2 wasmeasured). The averagemeal volume
was 361.4 ± 3.4ml and contained 27.4 g of protein, 48.5 g of fat,
and 88.4 g of carbohydrate, plus significant amounts of vitamins
andminerals. Participants were asked to consume the entire meal
portion provided.
Blood Sampling
Blood samples (6ml) were drawn at regular intervals through
a catheter (Baxter Health Care, Valencia, CA) inserted into a
dorsal hand vein at the beginning of the experiment. The subject’s
catheterised hand was placed in a hot air box (50–55◦C) to
maintain a constant high hand skin temperature and provide
arterialised venous blood. Arterialised venous blood samples
were collected in the fasted state prior to the test meal (one
sample 15min before, and another ∼10 s before the meal), and
at regular intervals during the 2 h following the ingestion of the
test meal, tomonitor blood glucose (every 10min), and to analyse
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the responses of serum insulin and plasma glucagon-like peptide
(GLP-1), peptide YY (PYY), and ghrelin (every 15min). Plasma
catecholamine (noradrenaline and adrenaline) responses were
additionally measured in the fasting state and post-prandially.
The plasma level of leptin was also measured in the fasted state
before and after each confinement.
The blood glucose level was analyzed immediately from
each arterialised venous blood sample (HemoCue, HMC-201-
PROMO, Sweden). For subsequent hormone analyses, all blood
samples were either immediately (or after 10min, in the case of
the insulin tube to allow clotting) centrifuged at 3000 rpm for
10min (at a temperature of 4◦C), and aliquots kept on ice until
the end of the MTT and stored at−20◦C for 1 day, and thereafter
at−70◦C for further analyses. The analysis of all plasma samples
was conducted in duplicate using the assays described below.
Insulin concentrations were determined using radio-
immunoassay (RIA) (Insulin Coat-A-Count, Diagnostic
Products Corp., Los Angeles, USA); GLP-1 concentrations
(comprising GLP-1 7–36 amide and 7–37) using Enzyme-Linked
ImmunoSorbent Assay (ELISA) (Merck Millipore, Missouri,
USA); PYY using RIA for total PYY (Merck Millipore, Missouri,
USA), which recognized both PYY1-36 and PYY3-36 in EDTA
plasma plus aprotinin; ghrelin was determined using RIA for
total ghrelin (Merck Millipore, Missouri, USA) and leptin
was determined using a human leptin RIA (Merck Millipore,
Missouri, USA). Catecholamines were measured using extraction
of the adrenaline and noradrenaline from the plasma (which
had been treated with EGTA/glutathione (Sigma-Aldrich,
Dorset, UK) as a preservative) followed by high performance
liquid chromatography (HPLC) with electrochemical detection
(Forster and MacDonald, 1998).
Labeled glucose artificially enriched with (U-13C) glucose
(13C/C >99%; Isotec, Miamisburg, OH, USA) was dissolved in
each individual’s liquid meal so that the appearance of 13CO2 in
the expired air could be used as a marker of the combination
of gastric emptying, uptake and oxidation of the test meal.
This breath testing is based on the principle that an ingested
substrate is metabolized, and a measurable metabolite is then
expelled by the respiratory system. Therefore, breath samples
were collected simultaneously with the blood samples before and
after the meal (at −15, 0, 15, 30, 45, 60, 75, 90, 105 and 120min)
using a breath-sampling bag (500ml) with a one-way valve for
capture of normal exhaled air. To allow analysis of 13C/12C
in expired CO2, 20ml samples of expired gases were collected
from the breath-sampling bag via a catheter (Baxter Health
Care, Valencia, CA) into evacuated tubes (vacutainers: Becton
Dickinson, Franklin Lakes, NJ) and stored until further analysis.
All samples were subsequently analyzed in triplicate with mass
spectrometry (Prism, VG, Manchester, UK) and 13C abundance
was calculated for all time points. The incremental postprandial
response (i.e., the 13C enrichment curve) was integrated and
presented as an area under the curve (AUC).
Appetite Sensation
Subjective perceptions of hunger, fullness, desire to eat, thirst and
prospective food consumption were assessed using a validated
visual analog scale (VAS; Stubbs et al., 2000). The VAS is a
100mm line, anchored to the left with “sensation not felt at all”
and to the right with “sensation felt the greatest”; subjects were
asked to place a vertical line in relation to their feeling at that
particular point in time, these scores were then summed to form
the Composite Satiety Score (CSS) according to the following
equation (the higher the score, the higher the level of subjective
satiety).
CSS = (Full+ (100−Desire)+ (100−Hunger)+ (100− PFC))/4
Intestinal Blood Flow
Blood flow was measured in the proximal portion of the
SMA, 2–5 cm distally to its origin in the aorta. Flow was
estimated by measurements of vessel-lumen diameter and
mean flow-velocity, using ultrasonographic/Doppler techniques
(MicroMaxx, SonoSite Inc., WA, USA). Flow velocity was
measured using a 2–5MHz linear array Doppler transducer
that was kept aligned with the vessel; the angle correction of
the transducer was maintained at <60◦ and its sample volume
was adjusted to cover more than 75% of the vessel lumen. The
diameter of the SMA was measured in B-mode image during
end-diastole (determined from the ECG), as wall-to-wall distance
in the sagittal section. Assuming that the artery had a circular
cross-section, flow was subsequently calculated by multiplying
vessel cross-sectional area by the mean flow-velocity. Each flow
determination was the average of measurements from 3 to 4
consecutive heart beats, repeated 2–3 times, i.e., the average of
data from 6 to 12 beats. The same sonographer performed all
measurements.
Calculations and Statistical Methods
Mass spectrometer analysis of breath samples provided a delta
value (δ), which was used to calculate abundance (atom %)
at each time point using standard methods (Pouteau et al.,
1998). Enrichment of breath samples was then obtained by
standardizing postprandial values to those at baseline.
The homeostatic model assessment (HOMA) method was
used to quantify fasting insulin resistance and β-cell function
(Matthews et al., 1985). The nonlinear model of two types of
HOMA scores were used:
HOMA IR = insulin resistance =
= (fasting insulin in mU·l−1)
× (fasting plasma glucose in mmol·l−1)/22.5
HOMA β = β-cell function[%] =
= 20× (fasting insulin in mU·l−1)/
((fasting glucose in mmol·l−1)− 3.5).
A 2-way ANOVA (NORMOXIA-HYPOXIA, Pre-Post) with
repeated measures was used to define the effect of the 10-
day confinements on the measured variables. A Tukey post
hoc test was used to assign the specific differences in the
analysis of variance. Additionally, some data were presented
as calculated area under curve (AUC) and compared with the
same type of ANOVA. Differences between the post HYPOXIA
and post NORMOXIA confinement cardiorespiratory responses
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and haematological values were compared with a one-tailed
t-test. Values are mean ± SD unless indicated otherwise. The
significance level was set at 0.05.
RESULTS
There was no significant change in body mass in the
NORMOXIA, and HYPOXIA confinements. Total body fat mass
significantly increased in NORMOXIA (p = 0.04), whereas no
difference between pre- and post-measurements was observed
in HYPOXIA (Table 1). In the abdominal region, absolute fat
content increased in NORMOXIA (p = 0.01), but exhibited a
tendency toward a decrease in HYPOXIA (p = 0.08). There was
also a tendency, albeit not significant, of a reduction in lean body
mass after NORMOXIA (p = 0.06).
The hemoglobin level at the end of the HYPOXIA
confinement was greater than that observed upon completion of
the NORMOXIA confinement (Table 1).
As observed in Table 1, there was no significant change in the
resting oxygen uptake (V˙O2rest) and minute ventilation (V˙Erest)
during the 10-d NORMOXIA and HYPOXIA confinements.
V˙O2rest and V˙Erest were significantly higher on day 10 of
the HYPOXIA confinement compared to the NORMOXIA
confinment. V˙O2peak was not significantly affected by the
NORMOXIA or HYPOXIA confinements (Table 1). These data
have been discussed in a previous report (see Kounalakis et al.,
2013).
In addition, no significant differences were observed in
systolic arterial pressure (SAP) or diastolic arterial pressure
(DAP), between before and after the NORMOXIA (SAP:
pre = 118 ± 8mmHg, post = 115 ± 8mmHg; DAP: pre = 79
± 6mmHg, post = 75 ± 7mmHg) and HYPOXIA (SAP:
pre = 119 ± 9mmHg, post = 123 ± 9mmHg; DAP: pre = 80
± 6mmHg, post= 85± 9mmHg).
A lower energy intake was observed in the HYPOXIA (p =
0.02), with mean daily energy intake being 2847 ± 241 and 2472
± 251 kcal·day−1 in NORMOXIA and HYPOXIA, respectively
(Figure 2).
The postprandial blood flow in the SMA increased
after the meal, with peak values being observed 30min
postprandially (mean increase of 456 ± 15ml·min−1) (Table 2).
Thereafter, mesenteric arterial flow decreased, but remained
elevated above the baseline value (by 123 ± 6ml·min−1)
for the remainder of the postprandial period. Mesenteric
arterial flow response was not significantly different after
the 10-day NORMOXIA and HYPOXIA confinements
(Table 2). The coefficient of variation for the ultrasound
measurements were 1.56% for arterial diameter, and 9.29%
for arterial flow. The former can be attributed to the
sonographer, and the latter to the physiological variability
in the response.
TABLE 1 | Body composition, cardiorespiratory and hematological responses before (PRE) and after (POST) the 10-day NORMOXIA and HYPOXIA
confinements.
Variable NORMOXIA HYPOXIA
Pre Post Pre Post
BODY COMPOSITION
Body mass (kg) 73.0±7.7 72.4± 7.0 72.3±5.9 71.4±6.3
Body mass index (BMI, kg·m−2 ) 22.3±2.4 22.0± 2.7 22.1±1.8 21.8±2.0
Total fat mass (%) 14.6±5.8 15.0± 6.1 14.6±6.1 14.6±5.5
Total fat mass (kg) 10.9±5.5 11.1± 5.4* 10.7±5.3 10.6±4.8
Abdominal fat mass (%) 11.9±6.3 12.7± 6.7* 11.9±6.6 11.8±5.8
Right thigh (%) 14.9±6.9 15.9± 7.3 14.9±6.6 14.5±6.7
Left thigh (%) 15.3±6.3 15.5± 6.2 14.9±6.5 14.9±6.0
Fat free mass (%) 85.4±5.8 85.0± 6.0* 85.4±6.1 85.4±5.5
Fat free mass (kg) 62.2±5.2 61.3± 5.0 61.6±4.9 60.8±4.7
RESTING CARDIORESPIRATORY RESPONSES
Heart rate (beats·min−1 ) 77±13 81± 15 79±16 85±13
V˙O2 (ml·kg
−1·min−1 ) 7.33 + 1.03 6.86 + 1.12 7.29 + 1.09 7.36 + 1.26†
V˙Erest (L. min
−1 ) 15.4 + 2.09 14.21 + 2.06 14.73 + 2.05 15.89 + 1.47†
RQ 0.84 + 0.05 0.86 + 0.04 0.87 + 0.1 0.84 + 0.05†
MAXIMUM OXYGEN UPTAKE
V˙O2 (ml·kg
−1·min−1 ) 61.2±7.2 61.8± 7.0 62.6±6.1 62.4±5.9
HEMATOLOGICAL VARIABLES
Hemoglobin (g·l−1) 146.4±0.9 144.5± 0.8 147.2±0.9 148.4±0.9†
Hematocrit (%) 44.2±2.4 43.9± 2.3 44.9±2.3 45.5±3.1
Values are mean , SD, n = 11.
V˙O2, oxygen uptake; *, significant differences (p < 0.05) between pre and post confinement; (†), significant differences (p < 0.05) between post HYPOXIA and post NORMOXIA
confinement.
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FIGURE 2 | Daily energy intake (kcal.day−1) during the normoxic and
hypoxic confinements.
There were no changes in fasting ghrelin levels after each
confinement (Table 2). Ghrelin decreased postprandially (p <
0.001), but the response did not change during any confinement,
or differ between them (Table 2).
In the fasted state, PYY was not significantly different
between the confinements. Postprandially, PYY increased (p <
0.001), in a similar manner (p = 0.46), in both confinements
(Table 2).
In the fasted state, noradrenaline, but not adrenaline, was
significantly increased only by HYPOXIA (p = 0.04). There
was a statistical tendency for elevated postprandial levels of
noradrenaline in the HYPOXIA (p = 0.07). There were no
significant postprandial changes of adrenaline either before or
after each confinement (Table 2).
Subjective satiety (CSS) in the fasted state remained unaltered
after both confinements (p = 0.19). CSS increased after the test
meal, but there were no differences between the confinements
(Table 2).
Leptin levels in the fasted state significantly increased after
both confinements. In NORMOXIA, the absolute leptin values
in the fasting state increased from 3.0 ± 2.1µg·l−1 to 3.6 ±
2.4µg·l−1 (p = 0.04); while in HYPOXIA they increased
from 2.6 ± 2.3µg·l−1 to 3.6 ± 2.8µg·l−1 (p = 0.02).
There was no significant difference between the responses
in NORMOXIA and HYPOXIA (p = 0.53) both with
and without the change in fat mass used as a co-variate
(p = 0.52).
Blood glucose levels in the fasted state were unchanged in
NORMOXIA and HYPOXIA (Figure 3). Fasting insulin and
fasting GLP-1 were higher after NORMOXIA (p = 0.01;
p = 0.02), but not after HYPOXIA. Postprandially, glucose
was elevated in NORMOXIA and HYPOXIA until the 40th
min, and then gradually decreased (Figure 4). Postprandially,
insulin initially increased in all conditions, and then gradually
decreased until the end of the 2-h measurement. After the 10-
day confinement period, insulin was higher (p < 0.05) in
both NORMOXIA and HYPOXIA compared with the values
observed in the pre-tests (Figure 4). GLP-1 increased after the
meal, and the response was similar for both confinements
(Figure 3).
HOMA IR significantly increased in NORMOXIA (pre: 0.6±
0.3, post: 0.9± 0.4; p = 0.03), while no differences were observed
in HYPOXIA (pre: 0.5 ± 0.3, post: 0.5 ± 0.4). HOMA-β was
significantly different after each confinement (p = 0.03), with no
differences between them (NORMOXIA: pre: 46.9 ± 33.8, post:
81.5 ± 45.3 and HYPOXIA: pre: 57.7 ± 52.0, post: 64.5 ± 44.2;
p = 0.77).
The enrichment of 13-C in expired air, derived from labeled
glucose, increased after the meal (Figure 5; p < 0.001),
although it did not differ between confinements (p = 0.71).
Thus, there was no evidence of impaired dietary glucose
availability following HYPOXIA, and the speed with which
ingested glucose was absorbed and metabolized was not altered
by this confinement.
DISCUSSION
The principal finding of the present study is that a continuous 10-
day exposure to normobaric hypoxia without the confounding
factor of strenuous physical activity caused a decrease in dietary
intake. The higher resting oxygen uptake (V˙O2rest) observed at
the end of the hypoxic confinement compared to the normoxic
confinement although statistically significant, may not be of
physiological relevance. Namely, it may be argued that the
observed significant differences in V˙O2rest and V˙Erest observed
in the present study are attributable more to the observed
tendency, albeit not significant, of a decrease in V˙O2rest and
V˙Erest in the normoxic condition, rather than an increase in the
hypoxia condition. We also observed a slight increase in body
fat mass during NORMOXIA, whereas no change was observed
during the HYPOXIA confinement.
Our observation of reduced energy intake during the
HYPOXIA confinement concurs with the reported loss of
appetite after a 31-day hypobaric hypoxic exposure in laboratory
conditions (Westerterp-Plantenga et al., 1999), and the
suppressed energy intake after a 7-h exposure to normobaric
hypoxia (Wasse et al., 2012). The present subjects ate ad libitum,
and no change in appetite was detected by the CSS after the
test meal. A reduction in energy intake is consistent with the
suggested altitude anorexia mediated by leptin (Tschöp et al.,
1998), which is thought to regulate food intake and energy
expenditure. In NORMOXIA the increased fasting leptin could
be explained on the basis of the tendency for increased body
fat mass, whereas in the HYPOXIA confinement the leptin
increased, despite a trend for a reduced total fat content. This
increase in leptin levels might be related to the decreased food
intake. Our observed leptin response is in agreement with studies
reporting increased leptin levels after hypoxic exposure (Shukla
et al., 2005; Mazzeo, 2008; Snyder et al., 2008). Furthermore,
it has been reported that hypoxia-treated cells up-regulate
obese (ob) gene transcription, suggesting that enhancement
of leptin secretion in vivo under hypoxic conditions may be a
mechanism to consider when developing therapeutic methods
for obesity treatment (Yingzhong et al., 2006). However,
equivocal leptin levels after HYPOXIA, could be due to high
intra-individual responses, as well as differences in the degree
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TABLE 2 | Fasted and mean postraprandial mesenteric arterial blood flow, ghrelin, peptide YY3−36(PYY), adrenaline and noradrenaline and subjective
composite satiety score (CSS) evaluation before (PRE) and after (POST) the 10-day NORMOXIA and HYPOXIA confinements.
Fasted state Postprandial state
Confinement Time (min)
0 30 60 90 120
MESENTERIC ARTERIAL BLOOD FLOW (ml·min−1)
NORMOXIA Pre 149.7± 6.7 530.6± 26.1 400.6± 20.7 279.0± 13.9 263.6± 14.7
Post 131.8± 8.5 593.1± 20.8 409.5± 14.7 316.5± 13.7 251.7± 10.3
HYPOXIA Pre 146.0± 8.0 627.1± 29.4 455.9± 22.8 287.0± 13.8 233.6± 10.5
Post 142.8± 5.4 646.0± 19.1 420.5± 9.6 332.4± 13.2 316.2± 12.2
GHRELIN (pg·ml−1)
NORMOXIA Pre 1190.4± 34.2 1057.4± 22.2 959.9± 22.8 971.5± 22.8 962.1± 24.3
Post 1163.3± 35.2 1010.7± 26.8 950.2± 23.4 842.9± 25.7 835.6± 24.6
HYPOXIA Pre 1030.4± 32.4 921.2± 19.2 864.6± 19.6 830.1± 23.5 830.2± 19.4
Post 1176.8± 32.4 1015.0± 24.0 935.6± 23.1 911.4± 21.9 919.6± 31.1
LEPTIN (ng·ml−1)
NORMOXIA Pre 3.02± 0.19
Post 3.56± 0.22
HYPOXIA Pre 2.60± 0.21
Post 3.63± 0.26
PYY (pg·ml−1)
NORMOXIA Pre 100.0± 37.5 128.6± 31.1 118.1± 23.2 111.5± 21.0 131.9± 22.7
Post 114.9± 28.8 144.6± 28.7 126.1± 24.6 129.5± 21.6 128.2± 24.3
HYPOXIA Pre 97.7± 27.2 128.8± 41.5 118.0± 35.6 125.8± 33.7 122.1± 33.7
Post 107.2± 19.4 142.8± 30.1 133.9± 31.4 137.1± 30.9 139.9± 31.1
ADRENALINE (nmol·l−1)
NORMOXIA Pre 0.31± 0.01 0.19± 0.01 0.21± 0.01 0.22± 0.01 0.26± 0.01
Post 0.27± 0.01 0.15± 0.01 0.21± 0.01 0.21± 0.01 0.22± 0.01
HYPOXIA Pre 0.30± 0.02 0.20± 0.02 0.18± 0.00 0.16± 0.01 0.24± 0.01
Post 0.26± 0.01 0.16± 0.01 0.18± 0.00 0.17± 0.01 0.22± 0.01
NORADRENALINE (nmol·l−1)
NORMOXIA Pre 0.89± 0.02 1.02± 0.03 0.99± 0.03 0.98± 0.02 0.94± 0.03
Post 0.77± 0.02 0.91± 0.02 0.81± 0.02 0.84± 0.03 0.86± 0.03
HYPOXIA Pre 1.01± 0.03 1.19± 0.04 1.01± 0.03 0.99± 0.02 1.03± 0.03
Post 1.30± 0.04* 1.52± 0.07 1.49± 0.05 1.52± 0.06 1.47± 0.05
CSS EVALUATION (mm)
NORMOXIA Pre 31.8± 2.0 53.1± 2.9 53.8± 3.4 41.8± 2.8 34.9± 2.8
Post 31.1± 2.1 47.2± 2.7 44.4± 2.7 40.8± 2.5 38.0± 2.6
HYPOXIA Pre 38.3± 2.2 55.9± 2.9 53.9± 2.8 48.0± 2.4 46.0± 2.6
Post 37.3± 2.0 55.2± 2.9 55.3± 2.9 45.9± 2.8 44.6± 2.8
Values are mean ± SEM, n = 11.
CSS, composite satiety score; *, significant differences between pre and post confinement; p < 0.05.
of hypoxic exposure (Mazzeo, 2008). In obesity leptin levels
are already elevated but this does not lead to a suppression of
energy intake so a further increase may not be of particular
benefit.
Similar to other studies, we observed no change in ghrelin
levels during the HYPOXIA confinement, although the ghrelin
level decreased after the meal as expected in a normal
postprandial response (Cummings et al., 2001). In agreement
with others (Lippl et al., 2010), the HYPOXIA confinement did
not significantly decrease the fasting ghrelin, most likely due
to the fact that the absolute amount of weight loss was small.
Unchanged ghrelin levels have also been reported, concomitant
with significant reductions of 5 kg in body mass (Benso et al.,
2007). It has been suggested that PYY can inhibit ghrelin neurons
and consequently ghrelin secretion (Riediger et al., 2004). In
the present study, PYY was unchanged after HYPOXIA, which
does not support the theory that it contributes to high-altitude
anorexia.
Westerterp et al. (1992, 1994), who observed reduced body
weight mainly due to fat loss during a Mt. Everest climb
Frontiers in Physiology | www.frontiersin.org 8 June 2016 | Volume 7 | Article 202
Mekjavic et al. Normobaric Hypoxia and Metabolism
FIGURE 3 | Circulating glucose, serum insulin and GLP-1 values in fasted (A) and postprandial state (mean of 2 h, B), before (PRE) and after (POST)
10-day normoxic (NORMOXIA; A) and hypoxic (HYPOXIA; B) confinement. Values are mean ± SEM. *Indicates significant difference between PRE and POST
confinement (p < 0.05).
(>5000 m, 3 weeks), reported no significant differences in resting
metabolic rate measured by respiratory gas analysis at sea level
and at high altitude. In most of the field studies, a number
of environmental factors (hypobaric hypoxia, cold) and intense
physical activity might affect metabolic rate. However, there
are indications of increased REE in altitude studies (Grover,
1963; Gill and Pugh, 1964; Stock et al., 1978). Furthermore,
Pulfrey and Jones (1996) reported that climbing to nearly 8000m
required 536 kcal/day just for the acclimatization to altitude,
which did not include energy expenditure for physical exertion.
Moreover, Butterfield et al. (1992) reported a 27% transient
increase of REE on day 2 at altitude, followed by a plateau
at 17% above the sea level REE by day 10. Reynolds et al.
(1999) reported that REE ranged from 1.85 up to 3.82 times
higher than the REE measured at sea level before the expedition,
with the mean of 2.98 ± 0.70 for the climbers, and of 2.43
± 0.45 for the base camp individuals. Again, all the previous
evidence of increased REE at high altitude were related to even
lower oxygen availability due to pressure change at high altitude.
Lippl et al. (2010) confirmed that hypobaric hypoxia (with no
physical activity) contributed to increased REE, but there was no
evidence, that daily normobaric hypoxic confinement (frequently
used as hypoxic training for athletes) could affect metabolic
rate.
Circulating catecholamines can also stimulate EE (Cori
and Buchwald, 1930). Our finding of increased noradrenaline
after HYPOXIA is in line with other studies (Calbet, 2003;
Richalet et al., 2010), indicating enhanced activation of the
sympathetic nervous system (SNS) by hypoxia (Cutler et al.,
2004; Gilmartin et al., 2008). It has been demonstrated that
variability in REE can be explained by differences in SNS
activity (Webber and Macdonald, 2000). The increase in REE
induced by hypoxia per se may not be desirable for athletes
training in hypoxic conditions, as their energy requirements
may be higher. By contrast, this response to hypoxia might be
beneficial for obese individuals, in whom exercise limitation can
profoundly restrict daily activities, and lead to lower energy
expenditure.
The weight loss at altitude may not be entirely due to an
imbalance between the amount of food (energy) ingested and
EE. Slowed, and possibly impaired, absorption of nutrients at
altitude has also been suggested (Schoots et al., 2006) to reduce
the availability of the ingested energy. In contrast, it has been
reported that, at least up to an altitude of 5000 m, malabsorption
does not seem to play a critical role in altitude-related weight
loss (Kayser, 1994). In the present study, HYPOXIA did not
compromise the gut blood flow response to the test meal. We
did not observe any significant differences from the normal,
anticipated increase after the meal (Sidery and Macdonald, 1994;
Totman et al., 2009), nor were there differences in the responses
of superior mesenteric arterial flow between the NORMOXIA
and HYPOXIA confinements. Recently, it was suggested that the
suppression of acylated ghrelin during 7 h of hypoxic exposure
might be linked to impaired gut blood flow in response to
acute hypoxia (Wasse et al., 2012). In addition, the observation
of impaired postprandial gut blood flow (SMA) during acute
altitude exposure as a consequence of increased intestinal
sympathetic tone, suggests that, if sustained, may be related to
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FIGURE 4 | Relative change (1) in postprandial circulating glucose, and serum insulin values before (PRE) and after (POST) the 10-day normoxic
(NORMOXIC; A) and hypoxic (HYPOXIC; B) confinement. Values are mean ± SEM. *Indicates significant (p < 0.05) difference between PRE and POST
confinement; #indicates significant (p < 0.05) differences over time from the fasted state; § indicates significant (p < 0.05) differences over time from the peak values.
FIGURE 5 | Isotopic enrichement of expired CO2 expressed in atom percent excess (APE) in postprandial response before (PRE) and after (POST) the
10-day normoxic (NORMOXIC; A) and hypoxic (HYPOXIC; B) confinements. Values are mean ± SEM. *Indicates significant (p < 0.05) difference between PRE
and POST confinement.
reduced energy intake, during prolonged exposure (Loshbaugh
et al., 2006). However, our results concur with the previously
reported loss of appetite, which was not associated with any
reductions in gut blood flow during several days of exposure
to hypobaric hypoxia (Kalson et al., 2010). Thus, it appears
unlikely that impaired gut blood flow could be responsible for
high-altitude anorexia, as previously proposed. In addition, there
were no changes in the postprandial 13CO2 level in expired air
(derived from the ingested 13C-glucose) after confinement in
NORMOXIA or in HYPOXIA. This, together with the finding
of unaltered gut blood flow, provides evidence that HYPOXIA
did not induce malabsorption, and thus did not reduce the
availability of ingested energy.
Fasted insulin and GLP-1 were increased after the
NORMOXIA, but not after the HYPOXIA confinement.
Interestingly, a trend for statistical significance (p = 0.09)
toward decreased fasting blood glucose after the HYPOXIA
confinement was noted. Consequently, the HOMA IR index
was elevated after the NORMOXIA confinement only, and
the HOMA-β index was elevated after both the NORMOXIA
and HYPOXIA confinements, due to increased fasting insulin.
Post-prandially, a trend for elevated blood glucose only after
the HYPOXIA confinement was concomitant with the elevated
insulin response, which might suggest increased insulin
resistance due to hypoxia or to the imposed inactivity (Hamburg
et al., 2007; Olsen et al., 2008) in the physically well-trained
participants. Moreover, the reduction in insulin-mediated
peripheral glucose uptake could also be compounded by the
small decrease of fat-free mass, and presumably also by the
increase in SNS activation in hypoxia. Recently, Peltonen et al.
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(2012) demonstrated that SNS activation was also associated
with the disruption of glucose control. Therefore, the observed
tendency for insulin resistance could be, in part, due to a
hypoxia-induced SNS activation. Stock et al. (1978) reported
no changes either in fasting blood glucose levels, or in the
postprandial blood glucose response during the 1st week of
exposure to altitude (3650m), while after the 2nd week at high
altitude, there was a reduction in fasting and postprandial
blood glucose, and insulin levels. In contrast to our study, the
subjects in that study were exercising. In addition, compared
to our study the technique of blood sampling was different; in
particular, blood samples were drawn from the antecubital vein
in the field, whereas in the present study arterialised venous
blood samples were obtained. The former would lead to an
underestimation of the glucose response to a meal due to tissue
extraction. The observed tendency for an elevated postprandial
blood glucose response observed in the HYPOXIA confinement
was concomitant with unaltered adrenaline levels, in accordance
with previous observations (Pulfrey and Jones, 1996). Moreover,
our findings of significantly higher noradrenaline levels in the
fasted state in hypoxia, with a tendency of elevated postprandial
noradrenaline levels only after the HYPOXIA confinement are
consistent with the observations of increased activity of the SNS,
when oxygen availability is decreased (Gilmartin et al., 2008;
Peltonen et al., 2012).
The observed reduction of the ad libitum energy intake in
the HYPOXIA compared to the NORMOXIA confinement, most
likely contributed to the loss of mass in the former condition.
This is in line with the results of Abete et al. (2010), who reported
a weight loss of 0.5–1.0 kg week−1 in subjects whose energy intake
was restricted by 500–1000 kcal·day−1 compared to the usual
diet.
METHODOLOGICAL CONSIDERATIONS
A study investigating the effect of a stressor/factor on
metabolism, appetite and body composition, such as the present
study, can be conducted using two principal methodological
approaches. Either the subjects’ energy intake is limited, but
appropriately matching their energy expenditure, or the energy
intake is not limited (ad libitum). In the present study we
incorporated the latter approach, and thus did not anticipate any
differences in satiety scores between the normoxic and hypoxic
conditions. Differences would most likely have been evident
with a limited energy protocol. We opted for the ad libitum
protocol, since one of the principal aims of the study was to
assess whether indications of hypoxic anorexia as experienced
by alpinists was evident at lower altitude. Hypoxic anorexia
has been reported during high altitude expeditions, and would
not be of any significance at low altitudes, as simulated in the
present study. Nevertheless, we reasoned that this phenomenon
most likely starts to develop at some threshold altitude, and
indications of its onset might be observed. The reduced energy
intake observed in the hypoxia trial certainly suggests that this
component of the hypoxic anorexia phenomenon is evident at
altitudes simulated in the present study. Certainly, it would be
worthwhile repeating this protocol at higher altitudes.
In both trials subjects were ambulatory, but did not participate
in any physical exercise. The activity of the subjects was not
monitored continuously during the 10-d confinements, but was
similar. Any significant differences in physical activity would
have contributed to the outcomes.
The conventional method for estimating resting energy
expenditure is the ventilated hood method. This method is
acceptable for environments in which the oxygen fraction is
normal (FO2 = 0.2093) and does not fluctuate. In conditions,
where the oxygen fraction has been reduced, such as in the
present study, commercially available devices do not measure
the oxygen fraction of the gas entering and exiting the hood.
Only in this manner can the REE be reliably determined. In the
present method we measured resting oxygen uptake just prior
to a incremental load exercise. The subjects were resting, while
seated on a cycle ergometer, and the resting oxygen uptake was
measured over a 5-min period. Also, the subjects conducted the
exercise ∼4 h after consuming breakfast, and 1 h after a light
snack. As a consequence the resting oxygen uptake values are
higher than would be expected for a fasted individual resting
supine for several hours.
The purpose of the NORMOXIA confinement trial in the
present study was to be able to account for unexpected changes
that would be observed due to confinement, such as the observed
tendency for decreased resting oxygen uptake. Thus, if, for
reasons unknown, confinement per se does tend to reduce oxygen
uptake then our results also suggest that hypoxia is capable of
counteracting such a decrease.
CONCLUSIONS
In contrast to other studies, particularly field studies, we have
minimized and/or eliminated certain confounding factors, which
may contribute to weight loss during longer exposures at
higher altitudes, including cold stress, strenuous physical activity,
detraining, and unpalatable food. By carefully monitoring
nutritional intake and minimizing physical activity of the
subjects, our results focus on the direct effects of normobaric
hypoxia in the fasted state on postprandial metabolic responses.
Our results indicate metabolic changes, which may lead to
reduction in body weight, but it remains speculative whether
hypoxia of greater magnitude might induce more pronounced
weight loss. In conclusion, athletes and alpinists conducting
hypoxic training should be aware that hypoxia may lead to a
negative energy balance as a consequence of reduced energy
intake, and should monitor their energy intake to prevent such
loss in mass, which may ultimately have a detrimental effect on
performance.
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